›› 2015, Vol. 33 ›› Issue (8): 698-.doi: 10.3969 j.issn.1000-3606.2015.08.005

Previous Articles     Next Articles

Incidence and risk factor analysis of antibiotic-associated diarrhea of pediatric patients with severe bacterial pneumonia#br#  

LI Zihua1, CHENG Guoping1, WANG Zaihua2, ZHANG Zhen3, XIANG Yun3   

  1. 1.Department of Pediatrics, Tongcheng County People's Hospital of Hubei Province, Tongcheng 437400, Hubei, China; 2.Department of Emergency, Wuhan Children's Hospital, Wuhan 430016, Hubei, China; 3. Department of Laboratory, Wuhan Children's Hospital, Wuhan 430016, Hubei, China
  • Received:2015-08-15 Online:2015-08-15 Published:2015-08-15

Abstract: Objective To investigate the incidence and risk factors of antibiotic-associated diarrhea (AAD) of pediatric patients with severe bacterial pneumonia. Methods Clinical data of 1086 pediatric patients with severe bacterial pneumonia from January 2010 through January 2014 were recruited. The incidence and risk factors of AAD were retrospectively analyzed. Results The incidence of AAD in 1086 pediatric patients with severe bacterial pneumonia was 36.74%. The incidence of AAD in patients younger than 2 years old were higher than that in those older than 2 years, once or more times of mechanical ventilation history were higher than that with no arrangements of this treatment, administering of combined antibiotics therapy were higher than that with single antibiotics, and the incidence of AAD due to amoxicillin/clavulanate, piperacillin/tazobactam, cefoperazone/sulbactam in pediatric patients were 43.55%, 43.75%, and 45.03%, respectively. Three β-lactam/β-lactamase inhibitors above were risk factors of AAD through multivariate Logistic regression analysis. Conclusion The high incidence of AAD in pediatric patients with severe bacterial pneumonia was associated with some risk factors, including younger than 2 years old, mechanicalventilation, combined antibiotics therapy and administration of β-lactam/β-lactamase inhibitor (amoxicillin/clavulanate,piperacillin/tazobactam, cefoperazone/sulbactam).